| 臺大學術典藏 |
2021-07-03T03:35:48Z |
Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan
|
Yu M.-W.; Chang H.-C.; PEI-JER CHEN; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:46Z |
Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women
|
Yu M.-W.; Yang Y.-C.; Yang S.-Y.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; PEI-JER CHEN; Lin S.-C.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:45Z |
Hepatitis B e antigen and the risk of hepatocellular carcinoma
|
Yang H.-I.; Lu S.-N.; Liaw Y.-F.; You S.-L.; Sun C.-A.; Wang L.-Y.; Hsiao C.K.; PEI-JER CHEN; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:41Z |
Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk
|
Yu M.-W.; Chang H.-C.; Chang S.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; PEI-JER CHEN; Lin S.-C.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:38Z |
Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma
|
Yu M.-W.; Yang S.-Y.; Pan I.-J.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN; Lee S.-D.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:26Z |
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma
|
Chen C.-C.; Yang S.-Y.; Liu C.-J.; Lin C.-L.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Chen C.-J.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:35:22Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu M.-W.; Yeh S.-H.; PEI-JER CHEN; Liaw Y.-F.; Lin C.-L.; Liu C.-J.; Shih W.-L.; Kao J.-H.; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:12Z |
Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area
|
Shih W.-L.; Yu M.-W.; PEI-JER CHEN; Yeh S.-H.; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; Hsiao C.K.; Yang S.-Y.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:06Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou Y.-C.; Yu M.-W.; Wu C.-F.; Yang S.-Y.; Lin C.-L.; Liu C.-J.; Shin W.-L.; PEI-JER CHEN; Liaw Y.-F.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:04Z |
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
|
Yang H.-I.; Yeh S.-H.; PEI-JER CHEN; Iloeje U.H.; Jen C.-L.; Su J.; Wang L.-Y.; Lu S.-N.; You S.-L.; Chen D.-S.; Liaw Y.-F.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:34:53Z |
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study
|
Shih W.-L.; Yu M.-W.; PEI-JER CHEN; Wu T.-W.; Lin C.-L.; Liu C.-J.; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:45Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata M.; Lesmana L.A.; Tateishi R.; PEI-JER CHEN; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; Cheng A.L.; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K. |
| 臺大學術典藏 |
2021-07-03T03:34:43Z |
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
|
Yang H.-I.; Sherman M.; Su J.; PEI-JER CHEN; Liaw Y.-F.; Iloeje U.H.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:34:37Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang H.-H.; Shih W.-L.; Li Y.-H.; Wu C.-F.; PEI-JER CHEN; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:24Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Liu C.-J.; Lin C.-L.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:05Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:05Z |
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
|
Colvin R.A.; Tanwandee T.; Piratvisuth T.; Thongsawat S.; Hui A.J.; Zhang H.; Ren H.; PEI-JER CHEN; Chuang W.-L.; Sobhonslidsuk A.; Li R.; Qi Y.; Praestgaard J.; Han Y.; Xu J.; Stein D.S.; Chien R.-N.; Flisiak R.; Jablkowski M.; Liaw Y.-F.; Sung J.J.-Y. |
| 臺大學術典藏 |
2021-07-03T03:33:52Z |
The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network
|
Chang I.-C.;Huang S.-F.;Pei-Jer Chen;Chen C.-L.;Chen C.-L.;Wu C.-C.;Tsai C.-C.;Lee P.-H.;Chen M.-F.;Lee C.-M.;Yu H.-C.;Lo G.-H.;Yeh C.-T.;Hong C.-C.;Eng H.-L.;Wang J.;Tseng H.-H.;Hsiao C.-H.;Wu H.-D.I.;Yen T.-C.;Liaw Y.-F.; Chang I.-C.; Huang S.-F.; PEI-JER CHEN; Chen C.-L.; Chen C.-L.; Wu C.-C.; Tsai C.-C.; Lee P.-H.; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F. |
| 臺大學術典藏 |
2021-07-03T03:33:35Z |
Taiwan consensus statement on the management of chronic hepatitis B
|
Chien R.-N.;Kao J.-H.;Peng C.-Y.;Chen C.-H.;Liu C.-J.;Huang Y.-H.;Hu T.-H.;Yang H.-I.;Lu S.-N.;Ni Y.-H.;Chuang W.-L.;Lee C.-M.;Wu J.-C.;Pei-Jer Chen;Liaw Y.-F.; Chien R.-N.; Kao J.-H.; Peng C.-Y.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN; Liaw Y.-F. |
| 臺大學術典藏 |
2021-05-18T07:11:45Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu M.-W.;Yeh S.-H.;Chen P.-J.;Liaw Y.-F.;Lin C.-L.;Liu C.-J.;Wei-Liang Shih;Kao J.-H.;Chen D.-S.;Chen C.-J.; Yu M.-W.; Yeh S.-H.; Chen P.-J.; Liaw Y.-F.; Lin C.-L.; Liu C.-J.; WEI-LIANG SHIH; Kao J.-H.; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-05-18T07:11:44Z |
Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area
|
Wei-Liang Shih;Yu M.-W.;Chen P.-J.;Yeh S.-H.;Lo M.-T.;Chang H.-C.;Liaw Y.-F.;Lin S.-M.;Liu C.-J.;Lee S.-D.;Lin C.-L.;Hsiao C.K.;Yang S.-Y.;Chen C.-J.; WEI-LIANG SHIH; Yu M.-W.; Chen P.-J.; Yeh S.-H.; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; Hsiao C.K.; Yang S.-Y.; Chen C.-J. |
| 臺大學術典藏 |
2021-05-18T07:11:43Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang H.-H.;Wei-Liang Shih ;Li Y.-H.;Wu C.-F.;Chen P.-J.;Lin C.-L.;Liu C.-J.;Liaw Y.-F.;Lin S.-M.;Lee S.-D.;Yu M.-W.; Huang H.-H.; WEI-LIANG SHIH; Li Y.-H.; Wu C.-F.; Chen P.-J.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2021-05-18T07:11:43Z |
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study
|
WEI-LIANG SHIH; Yu M.-W.; Chen P.-J.; Wu T.-W.; Lin C.-L.; Liu C.-J.; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F. |
| 臺大學術典藏 |
2021-05-18T07:11:42Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
WEI-LIANG SHIH; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Liu C.-J.; Lin C.-L.; Yu M.-W. |
| 臺大學術典藏 |
2021-03-18T05:59:38Z |
Radionuclide venography in Budd-Chiari syndrome with intrahepatic vena-caval obstruction
|
Huang M.-J.; Liaw Y.-F.; KAI-YUAN TZEN |
| 臺大學術典藏 |
2021-03-18T05:59:36Z |
Choledochal cyst: findings of intravenous radionuclide cholescintigraphy, sonography, and endoscopic retrograde cholangiography
|
Kao P.F.; Huang M.J.; Liaw Y.F.; Chen H.Y.; KAI-YUAN TZEN |
| 臺大學術典藏 |
2021-03-18T05:59:32Z |
The clinical significance of gall-bladder non-visualization in cholescintigraphy of patients with choledochal cysts
|
Kao P.-F.; Huang M.-J.; KAI-YUAN TZEN; You D.-L.; Liaw Y.-F. |
| 臺大學術典藏 |
2021-02-02T07:51:01Z |
Lamivudine for patients with chronic hepatitis B and advanced liver disease
|
Liaw Y.-F.; Sung J.J.Y.; Chow W.C.; Farrell G.; Lee, Cha-Ze; Yuen H.; Tanwandee T.; Tao Q.-M.; Shue K.; Keene O.N.; Dixon J.S.; Gray D.F.; Sabbat J. |
| 臺大學術典藏 |
2020-12-28T08:14:08Z |
Taiwan consensus statement on the management of chronic hepatitis B
|
Hu T.-H.; Huang Y.-H.; Chen C.-H.; Liu C.-J.; Peng C.-Y.; Kao J.-H.; Chien R.-N.; Yang H.-I.; Lu S.-N.; YEN-HSUAN NI; Chuang W.-L.; Lee C.-M.; Wu J.-C.; Chen P.-J.; Liaw Y.-F. |
| 臺大學術典藏 |
2020-12-02T02:33:08Z |
Taiwan's health-care system and administration are independent of China
|
Tsai D.-H.;Lee M.-H.;Chen D.-S.;Liaw Y.-F.;Pan-Chyr Yang;Huang Y.-H.;Chen C.-J.; Tsai D.-H.; Lee M.-H.; Chen D.-S.; Liaw Y.-F.; PAN-CHYR YANG; Huang Y.-H.; Chen C.-J. |
| 臺大學術典藏 |
2020-11-19T03:43:12Z |
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives
|
Yu M.-W.;Chang H.-C.;Liaw Y.-F.;Lin S.-M.;Lee S.-D.;Liu C.-J.;Chen P.-J.;Hsiao T.-J.;Po-Huang Lee;Chen C.-J.; Yu M.-W.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Liu C.-J.; Chen P.-J.; Hsiao T.-J.; PO-HUANG LEE; Chen C.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:15Z |
The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network
|
Chen C.-L.; Chen C.-L.; Wu C.-C.; Tsai C.-C.; PO-HUANG LEE; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F.; Chen P.-J.; Huang S.-F.; Chang I.-C. |
| 臺大學術典藏 |
2020-07-01T06:54:59Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Cheng H.-Y.;Kang P.-J.;Ya-Hui Chuang;Wang Y.-H.;Jan M.-C.;Wu C.-F.;Lin C.-L.;Liu C.-J.;Liaw Y.-F.;Lin S.-M.;Chen P.-J.;Lee S.-D.;Yu M.-W.; Cheng H.-Y.; Kang P.-J.; YA-HUI CHUANG; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2018-09-10T08:41:23Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang, H.-H.;Shih, W.-L.;Li, Y.-H.;Wu, C.-F.;Chen, P.-J.;Lin, C.-L.;Liu, C.-J.;Liaw, Y.-F.;Lin, S.-M.;Lee, S.-D.;Yu, M.-W.; MING-WHEI YU; CHUN-JEN LIU; PEI-JER CHEN; WEI-LIANG SHIH |
| 臺大學術典藏 |
2018-09-10T08:13:48Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata, M.;Lesmana, L.A.;Tateishi, R.;Chen, P.-J.;Lin, S.-M.;Yoshida, H.;Kudo, M.;Lee, J.M.;Choi, B.I.;Poon, R.T.P.;Shiina, S.;Cheng, A.L.;Jia, J.-D.;Obi, S.;Han, K.H.;Jafri, W.;Chow, P.;Lim, S.G.;Chawla, Y.K.;Budihusodo, U.;Gani, R.A.;Lesmana, C.R.;Putranto, T.A.;Liaw, Y.F.;Sarin, S.K.; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:44:50Z |
Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers
|
Yu, M.-W.;Chiu, Y.-H.;Yang, S.-Y.;Santella, Rmm.;Chern, H.-D.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU; Yu, MW; Chiu, YH; Yang, SY; Santella, RM; Chern, HD; Liaw, YF; Chen, CJ |
| 臺大學術典藏 |
2018-09-10T07:44:50Z |
Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects
|
Yu, M.-W.;Chiu, Y.-H.;Chiang, Y.-C.;Chen, C.-H.;Lee, T.-H.;Santella, R.M.;Chern, H.-D.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T07:11:03Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou, Y.-C.;Yu, M.-W.;Wu, C.-F.;Yang, S.-Y.;Lin, C.-L.;Liu, C.-J.;Shin, W.-L.;Chen, P.-J.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU; Chou, YC; CHUN-JEN LIU; Yu, MW; Wu, CF; Yang, SY; Lin, CL; Liu, CJ; Shih, WL; Chen, PJ; Liaw, YF; Chen, CJ. |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update (Hepatology International 10.1007/s12072-008-9080-3)
|
Liaw, Y.-F.;Leung, N.;Kao, J.-H.;Teerha, P.;Gane, E.;Han, K.-H.;Guan, R.;Lau, G.K.K.;Locarnini, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:39:28Z |
Urinary aflatoxin metabolites and hepatocellular carcinoma - A nested case-control study
|
Lien, J.-P.;Yu, M.-W.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T06:04:40Z |
Chronic hepatitis B carriers with null genotypes of glutathione S- transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma
|
Chen, C.-J.;Yu, M.-W.;Liaw, Y.-F.;Wang, L.-W.;Chiamprasert, S.;Matin, F.;Hirvonen, A.;Bell, D.A.;Santella, R.M.; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T06:04:40Z |
L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers
|
Hsieh, L.-L.;Huang, R.-C.;Yu, M.-W.;Chen, C.-J.;Liaw, Y.-F.; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T05:25:11Z |
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2005 update
|
Liaw, Y.-F.; Leung, N.; Guan, R.; Lau, G.K.K.; Merican, I.; Mccaughan, G.; Gane, E.; Kao, J.-H.; Omata, M.; Chutaputti, B.A.; Chen, D.S.; Chien, R.N.; Cooksley, G.; Han, K.H.; Ichida, T.; Lai, M.Y.; Lesmana, L.; Piratvisuth, T.; Sarin, S.K.; Sollano, J.; Suh, D.J.; Yao, G.B.; Yeh, C.T.; Yokosuka, O.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T05:22:23Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu, M.-W.;Yeh, S.-H.;Chen, P.-J.;Liaw, Y.-F.;Lin, C.-L.;Liu, C.-J.;Shih, W.-L.;Kao, J.-H.;Chen, D.-S.;Chen, C.-J.Yu, Ming-Whei; Yeh, Shiou-Hwei; Chen, Pei-Jer; Liaw, Yun-Fan; Lin, Chih-Lin; Liu, Chun-Jen; Shih, Wei-Liang; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Chien-Jen; MING-WHEI YU; Yeh, Shiou-Hwei; CHUN-JEN LIU; Chen, Pei-Jer; Liaw, Yun-Fan; WEI-LIANG SHIH; Lin, Chih-Lin; DING-SHINN CHEN; Liu, Chun-Jen; JIA-HORNG KAO; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Chien-Jen |
| 臺大學術典藏 |
2018-09-10T04:36:54Z |
Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma
|
Yu, M.-W.;Yang, S.-Y.;Pan, I.-J.;Lin, C.-L.;Liu, C.-J.;Liaw, Y.-F.;Lin, S.-M.;Chen, P.-J.;Lee, S.-D.;Chen, C.-J.; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T04:36:54Z |
Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk
|
Yu, M.-W.;Chang, H.-C.;Chang, S.-C.;Liaw, Y.-F.;Lin, S.-M.;Liu, C.-J.;Lee, S.-D.;Lin, C.-L.;Chen, P.-J.;Lin, S.-C.;Chen, C.-J.; MING-WHEI YU; CHUN-JEN LIU; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T04:16:37Z |
Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women
|
Yu, M.-W.;Yang, Y.-C.;Yang, S.-Y.;Chang, H.-C.;Liaw, Y.-F.;Lin, S.-M.;Liu, C.-J.;Lee, S.-D.;Lin, C.-L.;Chen, P.-J.;Lin, S.-C.;Chen, C.-J.; MING-WHEI YU; CHUN-JEN LIU; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T04:16:37Z |
Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan
|
Yu, M.-W.;Chang, H.-C.;Chen, P.-J.;Liu, C.-J.;Liaw, Y.-F.;Lin, S.-M.;Lee, S.-D.;Lin, S.-C.;Lin, C.-L.;Chen, C.-J.; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T03:31:34Z |
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives
|
Yu, M.-W.;Chang, H.-C.;Liaw, Y.-F.;Lin, S.-M.;Lee, S.-D.;Liu, C.-J.;Chen, P.-J.;Hsiao, T.-J.;Lee, P.-H.;Chen, C.-J.; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T03:31:34Z |
Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: Impact of smoking on risk
|
Yu, M-W; Pai, C-I; Yang, S-Y; Hsiao, T-J; Chang, H-C; Lin, S-M; Liaw, Y-F; Chen, P-J; Chen, C-J; Yu, M-W; MING-WHEI YU; Pai, C-I; PEI-JER CHEN; Yang, S-Y; Hsiao, T-J; Chang, H-C; Lin, S-M; Liaw, Y-F; Chen, P-J; Chen, C-J |
